The Relationship between Serum Endocan Levels and Depression in Alzheimer’s Disease
Table 1
Demographic characteristics and clinical data of study subjects.
Variables
AD + depression ()
AD − depression ()
Control ()
Statistics
Sex (male/female)
4/22
7/22
11/18
0.157
Age (mean ± SD)
76.88 ± 7.86
76.83 ± 5.66
73.83 ± 4.24
0.098
Hypertension (, %)
15 (57.69 %)
19 (65.52 %)
13 (44.82 %)
0.260
BMI (mean ± SD)
22.53 ± 2.47
21.83 ± 2.60
23.35 ± 3.02
0.108
Smoking status (, %)
4 (15.38 %)
3 (10.34 %)
1 (3.45 %)
0.316
SGDS-K (mean ± SD)
10.15 ± 3.50
2.65 ± 2.48
0.52 ± 0.83
0.000
MMSE-KC (mean ± SD)
16.00 ± 3.46
14.90 ± 3.56
27.90 ± 1.59
0.000
CDR (mean ± SD)
0.96 ± 0.37
1.10 ± 0.60
0.00 ± 0.00
0.000
Note. AD + depression, Alzheimer’s disease with depression; AD − depression, Alzheimer’s disease without depression; Control, healthy control; SD, standard deviation; BMI, body mass index; SGDS-K, Korean version of the Geriatric Depression Scale-Short Form; MMSE-KC, Mini-Mental State Examination-Korean version; CDR, Clinical Dementia Rating.
